John is a seasoned investor, focusing on companies across frontier technology, enterprise software, robotics, healthcare, and artificial intelligence. He gravitates towards startups that are using science and technology to break down barriers to productivity growth and enable a better future for the largest number of people.
Prior to JAZZ, John was at Osage University Partners (OUP) and Lux Capital, where he focused on building and investing in companies at the intersection of science and deep technology. He brings extensive expertise in understanding nascent technologies and how they translate into product.
John’s prior investments and board roles include Algorithmia (acq. DataRobot), Body Labs (acq. AMZN), Corelight, Clarifai, Elementary ML, Embodied Robotics, Guardant Health (NYSE: GH), Kymeta, Menlo Security, SiFive, and Streetlight Data.
John holds a BS in Biology from Cornell University. John sits on the boards of several companies in the JAZZ portfolio, including Embodied, Rarebase, Oma Fertility, and Zeitworks.